CTLA4 and idiopathic pulmonary arterial hypertension: Our own studies have shown that in a group of patients with iPAH, there is a much higher percentage of CD4+ T cells with immune checkpoint proteins expression (CTLA-4 and programmed cell death receptor 1—PD-1) than in controls [103].